Nanotoxicology News

RSS

Providing a Quick and Precise View of Cell Development and Gene Expression

Providing a Quick and Precise View of Cell Development and Gene Expression

A team of University of Oregon biologists, using fruit flies, has created a way to isolate RNA from specific cells, opening a new window on how gene expression drives normal development and disease-causing breakdowns.

18 May 2009

An Efficient System for Delivering siRNA into Primary Cells

An Efficient System for Delivering siRNA into Primary Cells

In technology that promises to one day allow drug delivery to be tailored to an individual patient and a particular cancer tumor, researchers at the University of California, San Diego School of Medicine, have developed an efficient system for delivering siRNA into primary cells. The work will be published in the May 17 in the advance on-line edition of Nature Biotechnology.

17 May 2009

Efficient Synthesis of 'Mirror-Image' Molecules Now Possible in Water

Efficient Synthesis of 'Mirror-Image' Molecules Now Possible in Water

Replacing hazardous solvents with water and improving efficiencies are ways that chemists can reduce the environmental impact of their reactions-a central goal of the 'green chemistry' movement. Now, Yasuhiro Uozumi and colleagues from the RIKEN Advanced Science Institute in Wako have developed recyclable catalysts that selectively generate chiral organic molecules in water*-a nearly ideal green chemical process.

14 May 2009

Abraxis BioScience to Present Multiple Clinical Studies of ABRAXANE at 45th ASCO

Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated biotechnology company, today announced that multiple clinical studies of the chemotherapy agent ABRAXANE® for Injectable Suspension (paclitaxel protein-bound...

13 May 2009

Novel Approach to Assessing Engineered Nanoparticle Risk

The Institute of Occupational Medicine (IOM) is pleased to announce the launch of ENPRA - a major new European Framework 7 project to develop and implement a novel integrated approach for engineered nanoparticle (ENP) ri...

11 May 2009

Metabolon Announces Closure of $5.3 Million Series C Funding Round

Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, today announced that it has closed $5.3 million of an anticipated $11 million Series C funding round. This first portion closed on Apri...

8 May 2009

University Awarded £1.7 Million to Investigate how Nanotechnology Could Improve Effectiveness of Pharmaceutical Drugs

Scientists at the University of Liverpool have been awarded £1.7 million to investigate how nanotechnology could be used to improve the effectiveness of pharmaceutical drugs. Nanotechnology involves the manipul...

7 May 2009

Experts Present Evidence to Committee on Nanotechnology in Food

In a hearing held yesterday in the U.K. House of Lords, Professor Ken Donaldson from the University of Edinburgh and Dr Qasim Chaudhry from the Food and Environment Research Agency presented evidence to the Select Commit...

6 May 2009

Electrospun Nanofibers Hold Promise for Development of New Breathable Materials

In his office, MIT Professor of Chemical Engineering Gregory Rutledge keeps a small piece of fabric that at first glance resembles a Kleenex. This tissue-like material, softer than silk, is composed of fibers that are a ...

5 May 2009

NanoScale Corporation Announces Exclusive Distribution Agreement with Enware

NanoScale Corporation (NanoScale®), a leader in advanced chemistry products, services, and technologies, announces their exclusive distribution agreement with Enware of Australia for FAST-ACT® (First Applied Sorb...

5 May 2009

Previous
1
...
25
26
27
28
29
30
31
...
80
Next

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.